Anticentromere antibodies are most commonly associated with-
## **Core Concept**
Anticentromere antibodies (ACA) are a type of autoantibody that targets the centromere region of chromosomes. These antibodies are commonly found in patients with limited systemic scleroderma, also known as limited systemic sclerosis (lSSc). The presence of ACA is a diagnostic marker and helps in differentiating various forms of scleroderma.
## **Why the Correct Answer is Right**
The correct answer, **Limited Systemic Sclerosis (lSSc)**, is associated with anticentromere antibodies because these autoantibodies are highly specific for this condition. Limited systemic sclerosis is characterized by skin thickening limited to the extremities and face, and it often involves internal organs such as the esophagus, lungs, and kidneys. The anticentromere antibodies are directed against the centromeric proteins (CENP-A, CENP-B, CENP-C), which are components of the kinetochore. The presence of ACA in patients with lSSc is correlated with a more favorable prognosis compared to those with diffuse systemic sclerosis.
## **Why Each Wrong Option is Incorrect**
- **Option A: Rheumatoid Arthritis** - While rheumatoid arthritis is an autoimmune disease, it is not specifically associated with anticentromere antibodies. Rheumatoid arthritis is more commonly associated with rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs).
- **Option B: Systemic Lupus Erythematosus (SLE)** - SLE is another autoimmune disease that can have various autoantibodies, but anticentromere antibodies are not typically associated with SLE. Instead, SLE is associated with a wide range of autoantibodies, including anti-nuclear antibodies (ANA), anti-dsDNA, and anti-Sm.
- **Option C: Diffuse Systemic Sclerosis** - This condition is a subtype of systemic sclerosis characterized by widespread skin involvement. It is more commonly associated with anti-Scl-70 (topoisomerase I) antibodies rather than anticentromere antibodies.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of anticentromere antibodies is highly suggestive of **limited systemic sclerosis (lSSc)**, and these patients often have a better prognosis compared to those with diffuse systemic sclerosis. The detection of ACA can help in the diagnosis and differentiation of scleroderma subtypes.
## **Correct Answer:** . Limited Systemic Sclerosis.